CA-125 - Biomarker Kinetics

For patients with high grade serous ovarian carcinomas treated with first line platinum-based chemotherapy with 3 weekly-cycles (carboplatin – paclitaxel +/- bevacizumab).

CA-125 KELIM is calculated with 6 to 7 CA-125 values measured during the first 100 days after chemotherapy start (You et al. Proc ASCO 2017. Abs 5554. http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.5554)

CA-125 KELIM is calculated for information purpose only . The authors of this site do no take any responsability or endorse treatment decision.

Computing, please wait...

Favorable KELIM	≥ 1 associated with high tumor primary chemosensitivity, and better prognosis
Unfavorable KELIM	< 1 associated with poor tumor primary chemosensitivity, and worse prognosis

Modeled CA-125 KELIM For Prognostic Classification of Ovarian Cancer Patients Treated With First Line Chemotherapy

Patient information

Chemotherapy

CA-125 measured (UI/ml)

CA-125 KELIM